方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| 固体分散体制剂× | Caco-2 细胞渗透性测定× | |
|---|---|---|
| 领域 | 药理学 | 药理学 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 1971 | 1989 |
| 提出者≠ | William Chiou and Solomon Riegelman | Ingrid Hidalgo |
| 类型≠ | solubility enhancement | absorption screening |
| 开创性文献≠ | Chiou, W. L., Riegelman, S. (1971). Pharmaceutical applications of solid dispersions. Journal of Pharmaceutical Sciences, 60(9), 1281-1302. link ↗ | Hidalgo, I. J., Raub, T. J., & Borchardt, R. T. (1989). Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology, 96(3), 736-749. DOI ↗ |
| 别名 | solid solution, amorphous dispersion, polymer-based formulation | Caco-2 assay, intestinal permeability, ADME screening |
| 相关 | 3 | 3 |
| 摘要≠ | Solid dispersion is a formulation technique where a poorly soluble drug is molecularly dispersed in a hydrophilic polymer matrix, improving aqueous solubility and bioavailability. Introduced by Chiou and Riegelman in 1971, solid dispersions remain a key strategy for overcoming solubility-limited absorption. | The Caco-2 assay is an in vitro model system using human colon carcinoma cell monolayers to screen drug intestinal permeability. Developed by Hidalgo and colleagues in 1989, Caco-2 cells differentiate into an epithelial barrier resembling intestinal mucosa, enabling rapid assessment of drug absorption potential and identification of transporter-mediated transport. |
| ScholarGate数据集 ↗ |
|
|